UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000012164
Receipt number R000014223
Scientific Title Prospective study to investigate the performance of cytokine removal of polymethyl methacrylate hemofilters with two different membrane surface area
Date of disclosure of the study information 2013/10/30
Last modified on 2019/02/11 23:01:07

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Prospective study to investigate the performance of cytokine removal of polymethyl methacrylate hemofilters with two different membrane surface area

Acronym

Performance of cytokine removal of polymethyl methacrylate hemofilters with two different membrane surface area

Scientific Title

Prospective study to investigate the performance of cytokine removal of polymethyl methacrylate hemofilters with two different membrane surface area

Scientific Title:Acronym

Performance of cytokine removal of polymethyl methacrylate hemofilters with two different membrane surface area

Region

Japan


Condition

Condition

Severe sepsis, Septic shock

Classification by specialty

Infectious disease Emergency medicine Intensive care medicine

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To investigate the effect of membrane sufface area on the performance of sytokine removal, via measurement of 17 cytokines and
HMGB-1

Basic objectives2

Safety,Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Cytokine clearance of hemofilters, and duration those keep the clearance

Key secondary outcomes



Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

16 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

Svere sepsis/sptic shock patients with hypercytokinemia(IL-6 blood level is higher than 10000pg/mL) who recieve continuous hemodiafiltration using polymethylmethacrylate hemofilter

Key exclusion criteria

a) Patients who need to use smaller hemofiter (mambrane surface area:0.3m2 or 0.6m2)
b) under 15 years old
c) Pregnant woman
d) Patients whom doctors judge as out of the adaptation

Target sample size

20


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Shigeto Oda

Organization

Chiba University, Graduate School of Medicine

Division name

Department of Emergency and Critical Care Medicine

Zip code


Address

1-8-1 Inohana, Chuoh-ku, Chiba city, Chiba 260-8677, Japan.

TEL

043-226-2341

Email

kyukyu@office.chiba-u.jp


Public contact

Name of contact person

1st name
Middle name
Last name Noriyuki Hattori

Organization

Chiba University, Graduate School of Medicine

Division name

Department of Emergency and Critical Care Medicine

Zip code


Address

1-8-1 Inohana, Chuoh-ku, Chiba city, Chiba 260-8677, Japan.

TEL

043-222-7171

Homepage URL


Email

hat@shogo.com


Sponsor or person

Institute

Department of Emergency and Critical Care Medicine, Chiba University, Graduate School of Medicine

Institute

Department

Personal name



Funding Source

Organization

Department of Emergency and Critical Care Medicine, Chiba University, Graduate School of Medicine

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2013 Year 10 Month 30 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

No longer recruiting

Date of protocol fixation

2013 Year 08 Month 02 Day

Date of IRB


Anticipated trial start date

2013 Year 11 Month 01 Day

Last follow-up date

2016 Year 10 Month 01 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information

No data are available now.


Management information

Registered date

2013 Year 10 Month 30 Day

Last modified on

2019 Year 02 Month 11 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000014223


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name